Given the high efficacy of CP against B-leukemia phenotype and the bad prognosis of 4;11 translocated B-ALL, we further investigated the mechanism of action and the death pathways activated by CP in RS4;11 and SEM cells. Here, CP is linked to precursor B-cell acute lymphoblastic leukemia.